Pharmacological Action Table

Order Center

Life Science

Cell Signaling and Neuroscience

Cell Signaling Web Tools

New Products

PathFinder

Pathway Slides & Charts

Functional Genomics and RNAi

Peptides and Proteins

Plant Biotechnology

Proteomics and Protein Expr.

Stable Isotopes

Stem Cell Biology

Your Favorite Gene - Search

Life Science Innovations

PathFinder

Pharmacological Action Table
	Cell Signaling & Neuroscience

Adenosines/P2 Nucleotide Receptors (Purinergics)
Adrenergics
Biogenic Amines
Cholinergics
Dopaminergics
Excitatory Amino Acids
GABAergics
Histaminergics
Imidazoline Binding Site Ligands
Neuropeptides
Pharmacologicals
Serotonergics

Adenosines/P2 Nucleotide Receptors (Purinergics)
Product Name	Product #	Specificity
Adenosine agonists
Adenosine amine congener solid	A-111	A₁
2-Chloro-N⁶-cyclopentyladenosine solid	C-142	A₁
N⁶-Cyclohexyladenosine	C9901	A₁
N⁶-Cyclopentyladenosine solid	C8031	A₁
(S)-ENBA	E-111	A₁
(-)-N⁶-(2-Phenylisopropyl)adenosine solid	P4532	A₁
N⁶-p-Sulfophenyladenosine sodium salt solid	S-198	A₁
(+)-N⁶-(2-Phenylisopropyl)adenosine	P7665	A₁; less active enantiomer
2-Chloroadenosine	C5134	A₁,A₂
N⁶-Phenyladenosine solid	P-108	A₁,A₂
N⁶-(2-Phenylethyl)adenosine	P-107	A₁,A₂
Metrifudil	M-225	A₂
MECA solid	A-024	A₂,A₁
2-Phenylaminoadenosine >97 % solid	P-101	A₂,A₁
HE-NECA solid	H8034	A₂,A₃
CGS-21680 hydrochloride solid	C-141	A_2A
DPMA solid	D-130	A_2A
5'-(N-Ethylcarboxamido)adenosine powder	E2387	A_2B
N⁶-(4-Aminobenzyl)-N-methylcarboxamidoadenosine solid	A-236	A₃
N⁶-2-(4-Aminophenyl)ethyladenosine >95 %	A-202	A₃
N⁶-Benzyl-5'-N-ethylcarboxamidoadenosine solid	B-152	A₃
Chloro-IB-MECA solid	C-277	A₃
IB-MECA solid	I-146	A₃
I-AB-MECA solid	I-145	A₃ probe
Adenosine min. 99 %	A9251	Endogenous
Adenosine hemisulfate salt min. 98 %	A7636	Endogenous
Adenosine antagonists		back to top
CGS-15943 solid	C-199	A₁
7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine solid	C5982	A₁
8-Cyclopentyl-1,3-dimethylxanthine crystalline	C-102	A₁
8-Cyclopentyl-1,3-dipropylxanthine solid	C-101	A₁
1,3-Dimethyl-8-phenylxanthine crystalline	P2278	A₁
FSCPX	F7927	A₁
Xanthine amine congener	X-103	A₁
1,7-Dimethylxanthine approx. 98 % solid	D5385	A₁ > A₂
1,3-Dipropyl-8-(p-sulfophenyl)xanthine solid	A-022	A₁ > A₂
3-Isobutyl-1-methylxanthine min. 99 % (HPLC) powder	I5879	A₁ > A₂
3-Propylxanthine min. 99 % solid	P5679	A₁ > A₂
8-(p-Sulfophenyl)theophylline solid	A-013	A₁ > A₂
Theophylline anhydrous min. 99 % powder	T1633	A₁ > A₂
3,7-Dimethyl-1-propargylxanthine solid	D-134	A₂
Aminophylline hydrate min. 98 % powder	A1755	A₂ > A₁
8-(3-Chlorostyryl)caffeine solid	C-197	A_2A
SCH-58261 99 % (HPLC) solid	S4568	A_2A
Alloxazine solid	A-242	A_2B
MRS 1754 >98 % (HPLC)	M6316	A_2B
MRS 1191 solid	M-227	A₃
MRS 1220 solid	M-228	A₃
MRS 1523 >98 % (HPLC)	M1809	A₃
VUF 5574	V5888	A₃
Enzyme inhibitors		back to top
erythro-9-(2-Hydroxy-3-nonyl)adenine hydrochloride solid	E-114	Adenosine deaminase
P2 Receptor agonists		back to top
Cytidine 5'-triphosphate disodium salt approx. 98 %	C1506	Endogenous
Adenosine 5'-[g-thio]triphosphate tetralithium salt min. 75 % powder	A1388	P2
Adenosine 5'-triphosphate disodium salt Grade I min. 99 %	A2383	P2
2-(Methylthio)adenosine 5'-diphosphate trisodium salt >89 % solid	M-152	P2
2-(Methylthio)adenosine 5'-triphosphate tetrasodium salt >91 % solid	A-023	P2
Adenosine 5'-[b-thio]diphosphate trilithium salt min. 80 %	A8016	P2X
8-Bromoadenosine 5'-triphosphate sodium salt approx. 95 %	B3756	P2X
P¹,P⁴-Di(adenosine-5') tetraphosphate ammonium salt approx. 95 % (HPLC) powder	D1262	P2X
a,b-Methyleneadenosine 5'-triphosphate lithium salt min. 95 % solid	M6517	P2X > P2Y
b,g-Methyleneadenosine 5'-triphosphate disodium salt min. 95 % solid	M7510	P2X > P2Y
Adenosine 5'-diphosphate monopotassium salt dihydrate bacterial 98-100 % crystalline	A5285	P2X₁
Cytidine 5'-triphosphate disodium solution	C8552	P2X₃
2-Chloroadenosine triphosphate tetrasodium salt solid	C-145	P2Y
Uridine 5'-triphosphate trisodium salt solution	U1006	P2Y₂
Uridine 5'-diphosphate sodium salt from Saccharomyces cerevisiae 95-100 %	U4125	P2Y₆
P2 Receptor antagonists		back to top
P2 Receptor antagonists solid	P-178	P2
Suramin sodium salt min. 95 % solid	S2671	P2
NF 023 crystalline	N8652	P2X_1/3
TNP-ATP solid	T4193	P2X_1/3
Diinosine pentaphosphate pentasodium salt	D6938	P2X₁
MRS 2159 >98 % (HPLC) solid	M7684	P2X₁
PPNDS solid	P2738	P2X₁
Brilliant Blue G min. 90 % (TLC)	B5133	P2X₇
Adenosine 2',5'-diphosphate sodium salt min. 95 %	A5638	P2Y
Adenosine 3',5'-diphosphate sodium salt approx. 97 %	A5763	P2Y
Reactive Blue 2 solid	R-115	P2Y
MRS 2179 >98 % (HPLC)	M3808	P2Y₁
MRS 2395 ³98 % (HPLC) solid	M5942	P2Y₁₂
Transporter
Adenosine Transporter Receptor human Membrane suspension	A8352
Transport inhibitors		back to top
Dilazep dihydrochloride powder	D5294
Dipyridamole min. 98 % (TLC) powder	D9766
5-Iodotubericidin solid	I-100
S-(4-Nitrobenzyl)-6-thioinosine min. 98 % solid	N2255
Adrenergics		back to top
Product Name	Product #	Specificity
Agonists
6-Fluoronorepinephrine hydrochloride solid	B-012	a
Mephentermine hemisulfate salt	M3656	a
Metaraminol (+)-bitartrate salt	M4773	a
(±)-Octopamine hydrochloride solid	O0250	a
(±)-Synephrine min. 99 %	S0752	a
Tetrahydrozoline hydrochloride min. 98 %	T4264	a
Xylometazoline hydrochloride	X6000	a
Dihydroergotamine methanesulfonate salt powder	D2763	a (Partial)
(R)-(-)-Phenylephrine hydrochloride	P6126	a₁
Cirazoline hydrochloride solid	C-223	a_1A
Methoxamine hydrochloride	M6524	a_1A, Aa_1D
Naphazoline hydrochloride	N5504	a_1A, Aa_1D
Agmatine sulfate salt min. 97 % powder	A7127	a₂
p-Aminoclonidine hydrochloride solid	A0779	a₂
B-HT 920 dihydrochloride solid	B-162	a₂
B-HT 933 dihydrochloride solid	B-161	a₂
Clonidine hydrochloride solid	C7897	a₂
Guanabenz acetate salt solid	G-110	a₂
Guanfacine hydrochloride >98 % (HPLC)	G1043	a₂
Rilmenidine hemifumarate salt solid	R-134	a₂
UK 14,304	U-104	a₂
Xylazine min. 99 %	X1126	a₂
Xylazine hydrochloride min. 99 %	X1251	a₂
Moxonidine hydrochloride min. 98 %	M1559	a_2A
Oxymetazoline hydrochloride solid	O2378	a_2A (partial)
Bambuterol hydrochloride >98 % (HPLC) powder	B8684	b
(±)-CGP-12177 hydrochloride >98 % solid	C-125	b
Isoetharine mesylate salt	I3639	b
(±)-Isoproterenol hydrochloride	I5627	b
(-)-Isoproterenol (+)-bitartrate salt	I2760	b
(-)-Isoproterenol hydrochloride	I6504	b
(±)-Isoproterenol hemisulfate salt	I5752	b
Tulobuterol hydrochloride	T6050	b
R(-)-Denopamine >98 % (HPLC)	D7815	b₁
Dobutamine hydrochloride min. 98 %	D0676	b₁
Xamoterol hemifumarate salt >98 % (HPLC)	X3253	b₁ (Partial)
Clenbuterol hydrochloride min. 95 %	C5423	b₂
Fenoterol hydrobromide	F1016	b₂
Formoterol fumarate >98 % (HPLC)	F9552	b₂
Metaproterenol hemisulfate salt	M2398	b₂
Procaterol hydrochloride	P9180	b₂
Ritodrine hydrochloride	R0758	b₂
Salbutamol	S8260	b₂
Salbutamol hemisulfate salt	S5013	b₂
Salmeterol >98 % (HPLC) solid	S2692	b₂
Terbutaline hemisulfate salt	T2528	b₂
BRL 37344 sodium salt powder	B-169	b₃
CL 316,243 min. 98 %	C5976	b₃
(-)-Epinephrine	E4250	Endogenous a, b
(-)-Epinephrine (+)-bitartrate salt solid	E4375	Endogenous a, b
(±)-Epinephrine min. 98 %	E1635	Endogenous a, b
(±)-Epinephrine hydrochloride	E4642	Endogenous a, b
(-)-Norepinephrine (+)-bitartrate salt hydrate min. 99 % solid	A9512	Endogenous a, b₁
(-)-Norepinephrine min. 98 % crystalline	A7257	Endogenous a, b₁
(±)-Norepinephrine (+)-bitartrate salt	A0937	a, b₁
(+)-Isoproterenol (+)-bitartrate salt	I8005	Less active enantiomer
Antagonists
Phenoxybenzamine hydrochloride min. 97 % powder	B-019	a
Phentolamine hydrochloride min. 99 % (TLC) powder	P7547	a
Phentolamine methanesulfonate salt min. 99 % (TLC) powder	P7561	a
Spiroxatrine powder	S-103	a
Terazosin hydrochloride min. 98 % (TLC) powder	T4680	a
R(+)-Atenolol solid	A-142	a₁
Benoxathian hydrochloride solid	B-016	a₁
Doxazosin mesylate >98 % (HPLC)	D9815	a₁
Fiduxosin hydrochloride >98 % (HPLC)	F4303	a₁
Moxisylyte hydrochloride >99 % (TLC) powder	M5154	a₁
Naftopidil dihydrochloride solid	N-158	a₁
Urapidil hydrochloride solid	U-100	a₁
Prazosin hydrochloride min. 99 % (TLC) solid	P7791	a₁ (peripheral)
Prazobind solid	P-124	a₁ alkylating agent
5-Methylurapidil solid	U-101	a_1A
(±)-Niguldipine hydrochloride solid	N-134	a_1A
S(+)-Niguldipine hydrochloride solid	N-135	a_1A
WB-4101 hydrochloride >99 % (TLC) solid	D0411	a_1A
L-765,314 min. 98 %	L3040	a_1B
Spiperone solid	S7395	a_1B
Chloroethylclonidine dihydrochloride solid	B-003	a_1B alkylating agent
A-315456 >98 % (HPLC) solid	A6351	a_1D
BMY 7378 dihydrochloride >98 % solid	B-134	a_1D
Efaroxan hydrochloride	E3263	a₂
Idazoxan hydrochloride	I6138	a₂
MK-912 hydrochloride salt >98 % (HPLC)	M7065	a₂
Rauwolscine hydrochloride solid	R-104	a₂
RX 821002 solid	R9525	a₂
SKF 86466 solid	S1563	a₂
Tolazoline hydrochloride min. 99 % (titration) powder	T6886	a₂
Yohimbine hydrochloride min. 98 % (TLC) powder	Y3125	a₂
BRL 44408 maleate >99 % (HPLC) solid	B4559	a_2A
Imiloxan hydrochloride >98 % (HPLC)	I9531	a_2B
Labetalol hydrochloride >99 % (TLC) powder	L1011	b
(S)-(-)-Propranolol hydrochloride min. 99 % (TLC) powder	P8688	b
(±)-Propranolol hydrochloride min. 99 % (TLC) powder	P0884	b
(±)-Sotalol hydrochloride min. 98 % (TLC) powder	S0278	b
Atenolol min. 98 % (TLC) powder	A7655	b₁
S(-)-Atenolol solid	A-143	b₁
Betaxolol hydrochloride >98 % (HPLC)	B5683	b₁
CGP-20712A methanesulfonate salt solid	C-231	b₁
Cyclazosin hydrochloride solid	C-247	b_1B
(±)-Metoprolol (+)-tartrate salt min. 99 % (titration) powder	M5391	b₁
Timolol maleate salt min. 98 % (TLC) powder	T6394	b₁
Alprenolol hydrochloride >99 % (TLC) powder	A8676	b₁, b₂
Pindolol min. 98 % (TLC) powder	P0778	b₁, b₂
S(–)-Pindolol solid	P-152	b₁, b₂
ICI 118,551 hydrochloride min. 99 % (TLC) powder	I-127	b₂
Bromoacetyl alprenolol menthane powder	B-015	b₂ > b₁ alkylating agent
S(-)-Cyanopindolol hemifumarate salt solid	C-238	b₃
SR 59230A oxalate salt solid	S8688	b₃
(R)-(+)-Propranolol hydrochloride min. 99 % (TLC) powder	P0689	Less active enantiomer
Enzyme inhibitors
Benserazide hydrochloride min. 98 % (TLC) solid	B7283	L-Amino acid decarboxylase
S-(-)-Carbidopa >98 % solid	C-126	L-Amino acid decarboxylase
S(-)-Carbidopa: HBC complex	C-164	L-Amino acid decarboxylase
(±)-3-(3,4-Dihydroxyphenyl)-2-methyl-DL-alanine	M7277	L-Amino acid decarboxylase
3-Hydroxybenzylhydrazine dihydrochloride 95-98 % (TLC)	H9382	L-Amino acid decarboxylase
Ro 41-0960 solid	R-108	Catechol-O-methyltransferase
Fusaric acid from Gibberella fujikuroi	F6513	Dopamine b-hydroxylase
3-Phenylpropargylamine hydrochloride solid	P-106	Dopamine b-hydroxylase
1-Phenyl-3-(2-thiazolyl)-2-thiourea	P4015	Dopamine b-hydroxylase
R-(-)-Deprenyl hydrochloride solid	M-003	Monoamine oxidase
Hydralazine hydrochloride	H1753	Monoamine oxidase
Hydroxylamine hydrochloride min. 99 % (titration)	H9876	Monoamine oxidase
Hydroxylamine sulfate salt min. 99 % (titration)	H0127	Monoamine oxidase
Iproniazid phosphate salt	I7627	Monoamine oxidase
N-Methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine hydrochloride	M3778	Monoamine oxidase
Nialamide min. 95 % (HPLC)	N1392	Monoamine oxidase
Pargyline hydrochloride	P8013	Monoamine oxidase
Phenelzine sulfate salt	P6777	Monoamine oxidase
trans-2-Phenylcyclopropylamine hemisulfate salt	P1761	Monoamine oxidase
trans-2-Phenylcyclopropylamine hydrochloride	P8511	Monoamine oxidase
Quinacrine dihydrochloride min. 90 %	Q3251	Monoamine oxidase
Ro 41-1049 hydrochloride solid	R-107	Monoamine oxidase
Ro 16-6491 hydrochloride solid	R-106	Monoamine oxidase
(±)-2,3-Dichloro-a-methylbenzylamine hydrochloride solid	D-103	Phenylethanolamine N-methyltransferase
3-Iodo-L-tyrosine	I8250	Tyrosine hydroxylase
a-Methyl-L-tyrosine	M8131	Tyrosine hydroxylase
a-Methyl-DL-tyrosine methyl ester hydrochloride min. 98 % (TLC)	M3281	Tyrosine hydroxylase
Enzymes
Catechol-O-methyl Transferase porcine liver Lyophilized powder min. 1,000 units/mg protein	C1897
Phenylethanolamine N-Methyltransferase from bovine adrenal medulla Lyophilized powder	P8924
Metabolites		<